Soliqua 100/33 00024-5761-05
Generic: Insulin Glargine And Lixisenatide
- Manufacturer
- Sanofi-Aventis U.s. Llc
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 21, 2016
- Listing Expires
- December 31, 2027
- Application
- BLA208673
Need to source Soliqua 100/33? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Insulin Glargine | 100 U/mL |
| Lixisenatide | 33 ug/mL |
Drug Class
Insulin Analog [EPC]GLP-1 Receptor Agonist [EPC]GLP-1 Receptor Agonist [EPC]
Selected Package
00024-5761-05Selected5 SYRINGE in 1 CARTON (0024-5761-05) / 3 mL in 1 SYRINGE (0024-5761-02)
Other packages for this product(1)
1 SYRINGE in 1 CARTON (0024-5761-01) / 3 mL in 1 SYRINGE